Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 413-414

  Reich, Olaf ^a   Regauer, Sigrid ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Endometrial stromal sarcoma; Estrogen; Hormonal therapy; Tamoxifen

Indexed keywords

AROMATASE INHIBITOR; CLOMIFENE CITRATE; ESTROGEN; GESTAGEN; GONADORELIN DERIVATIVE; TAMOXIFEN;

CANCER GROWTH; DISEASE COURSE; ENDOMETRIUM SARCOMA; ESTROGEN THERAPY; FEMALE; GENETIC DISORDER; HORMONAL THERAPY; HUMAN; LETTER; METASTASIS; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT CONTRAINDICATION;

ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; SARCOMA, ENDOMETRIAL STROMAL; TAMOXIFEN;

EID: 33745906850     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.047     Document Type: Letter

References (5)

1. Pink D., Lindner T., Mrozek A., Kretzschmar A., Thuss-Patience P.C., Dörken B., et al. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 101 (2006) 464-469
2. Reich O., and Regauer S. Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study. Mod Path 17 (2004) 104-108
3. Reich O., and Regauer S. Do drugs that stimulate ovulation increase the risk for endometrial stromal sarcoma?. Hum Reprod 20 (2005) 1120
4. Reich O., and Regauer S. Endometrial stromal sarcoma-observational evidence of a genetic background?. Eur J Gynaecol Oncol 26 (2005) 288-290
5. Press M.F., and Scully R.E. Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. Gynecol Oncol 21 (1995) 135-154